Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer.
Saved in:
| Title: | Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer. |
|---|---|
| Authors: | Ricciuti B; Lowe Center of Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Fusco F; IRCCS Regina Elena National Cancer Institute, Rome, Italy., Cooper A; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Garbo E; Lowe Center of Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Pecci F; Lowe Center of Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Aldea M; Lowe Center of Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Wang X; Lowe Center of Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Mayoral Penalva M; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Ginsberg M; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Nishino M; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts., Di Federico A; Lowe Center of Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Shaverdian N; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Bott M; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Santo V; Lowe Center of Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Rendina E; Department of Thoracic Surgery, 'Sapienza' University of Rome-'Sant'Andrea' Hospital, Rome, Italy., Trisolini R; Interventional Pulmonology Division, Department of Neurosciences, Sense Organs and Thorax, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Ramella S; Department of Radiation Oncology (Medicine and Surgery), Università Campus Bio-Medico di Roma, Rome, Italy., Gallina F; IRCCS Regina Elena National Cancer Institute, Rome, Italy., Melis E; IRCCS Regina Elena National Cancer Institute, Rome, Italy., Buglioni S; IRCCS Regina Elena National Cancer Institute, Rome, Italy., Minuti G; IRCCS Regina Elena National Cancer Institute, Rome, Italy., Landi L; IRCCS Regina Elena National Cancer Institute, Rome, Italy., Ugalde Figueroa PA; Division of Thoracic and Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Shaw AT; Lowe Center of Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Chaft J; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Awad MM; Lowe Center of Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Cappuzzo F; IRCCS Regina Elena National Cancer Institute, Rome, Italy. |
| Source: | JAMA oncology [JAMA Oncol] 2025 Jul 01; Vol. 11 (7), pp. 735-741. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
